Nalls M

Title : BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells - Dela Cruz_2026_Anticancer.Res_46_1799

Author(s) : Dela Cruz MC , Yao X , Nealy A , Bailey J , Nalls M , Medina PM , Chen R , Biliran H

Ref : Anticancer Research , 46 :1799 , 2026

Abstract :

PubMedSearch : Dela Cruz_2026_Anticancer.Res_46_1799

PubMedID: 41895783

Title : Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome - Donkervoort_2020_Am.J.Med.Genet.A_182_2272

Author(s) : Donkervoort S , Mohassel P , Laugwitz L , Zaki MS , Kamsteeg EJ , Maroofian R , Chao KR , Verschuuren-Bemelmans CC , Horber V , Fock AJM , McCarty RM , Jain MS , Biancavilla V , McMacken G , Nalls M , Voermans NC , Elbendary HM , Snyder M , Cai C , Lehky TJ , Stanley V , Iannaccone ST , Foley AR , Lochmuller H , Gleeson J , Houlden H , Haack TB , Horvath R , Bonnemann CG

Ref : American Journal of Medicine Genet A , 182 :2272 , 2020

Abstract :

PubMedSearch : Donkervoort_2020_Am.J.Med.Genet.A_182_2272

PubMedID: 32776697

Nalls M

References (2)

1. BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells - Dela Cruz_2026_Anticancer.Res_46_1799

2. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome - Donkervoort_2020_Am.J.Med.Genet.A_182_2272